Preclinical models: status of basic research in depression.
about
Kappa-opioid ligands in the study and treatment of mood disordersProtein Kinase A and Anxiety-Related Behaviors: A Mini-ReviewIs increased antidepressant exposure a contributory factor to the obesity pandemic?Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disordersEpigenetics of the depressed brain: role of histone acetylation and methylationBehavioural profiles in captive-bred cynomolgus macaques: towards monkey models of mental disorders?Signal transduction and genes-to-behaviors pathways in psychiatric diseasesIncensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animalsNew approaches to antidepressant drug discovery: beyond monoaminesNovel sigma (sigma) receptor agonists produce antidepressant-like effects in miceRodent models of depression: neurotrophic and neuroinflammatory biomarkers.Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of miceDeletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviorsRapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3ηExpression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behavioursAnimal models of neuropsychiatric disordersThe specificity triad: notions of disease and therapeutic specificity in biomedical reasoning.Sex differences in animal models of psychiatric disorders.Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal grayDisinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state.Global down-regulation of gene expression in the brain using RNA interference, with emphasis on monoamine transporters and GPCRs: implications for target characterization in psychiatric and neurological disorders.Stress and depression: preclinical research and clinical implicationsAntidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibitionAge-modulated association between prefrontal NAA and the BDNF gene.Decreased Nucleus Accumbens Expression of Psychiatric Disorder Risk Gene Cacna1c Promotes Susceptibility to Social StressAntidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.17β Estradiol increases resilience and improves hippocampal synaptic function in helpless ovariectomized rats.Correlations between depression behaviors and sleep parameters after repeated corticosterone injections in ratsSocial isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stressBehavioral responses in rats submitted to chronic administration of branched-chain amino acids.Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed ratsDepression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptorsAntidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure.Animal models of depression: molecular perspectives.Abnormal anxiety- and depression-like behaviors in mice lacking both central serotonergic neurons and pancreatic islet cells.Adult depression-like behavior, amygdala and olfactory cortex functions are restored by odor previously paired with shock during infant's sensitive period attachment learning.In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice.α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy
P2860
Q24657982-E10F3CE4-ECEC-4691-A322-8E21E351B7B4Q26742185-A28C811E-2503-41BA-8B9D-11D55D152A8FQ26765430-200A1B02-FA73-4B89-BDC8-ED4CD29AC553Q26864720-9F133FC9-1776-49AE-823A-FF8B144CD9B6Q27015084-B8828B40-B1C4-42CE-A14B-ED6EBB045028Q27323164-1E9AE41A-4AE4-4BEF-A1C5-B9BC01F28EDDQ28182063-7458E7BF-451C-48E2-A3DE-9FBDC0DDA514Q28275851-CDAB6D82-8783-458C-802E-0E980C09BE0FQ28293089-22E79313-7DFE-48B9-93D6-9D1E18AEB676Q28294148-DF4973C1-1770-47B0-A1EC-0FD87154BE35Q28388439-393E02B6-7D52-4C41-90FC-35FB46BA6B1EQ28485938-DE34E5EF-19B8-42AC-AE23-22F8B3BE8A3AQ28512821-4DDDB3FE-BEF5-452A-9FA5-78A4398F6149Q28652455-0B06DBFB-1A9F-49CF-9CF4-D93DCC18163AQ28749410-282B23EB-3B38-4BF4-B715-C749D0E4A79DQ29619899-2BB69CCB-E47D-4EBA-A5A2-75947C8D1161Q30367922-AA9B2B24-A8F8-4771-A8A7-A366D17C9F77Q30401732-DD1C0C0C-2DC5-4A43-9E78-4B34A8D0DDC1Q30428091-BDDFE840-C3D1-4A62-BFA1-5C0282EC8247Q30482913-CA0C70C3-CA5D-4F2D-B62D-2D4D943E3E64Q30493545-9F44778B-9572-4CED-846E-D864525E43CFQ30848010-652FC498-5466-4B3C-AB20-964E53A97DA7Q33264255-DDE6FA79-5A6D-4B2E-8096-6C71D53A738EQ33404098-E14244D6-6823-46D2-B9A0-94DF1D870ADDQ33526872-371F87FB-ECC7-4CF1-ACFF-DF1DE1153F85Q33630799-5389C2FE-9E1A-4255-9660-605E331C0F91Q33636522-06C2BBCB-33B7-42C3-8D65-64C7191BB018Q33751924-8A16BAE5-E2F3-452E-B76F-7FEBFF8DC390Q33785921-7EB492E6-8128-4642-B755-C6CB7A0698E2Q33869747-448867EB-53B9-4BA6-8749-6A0F60C771B5Q33940576-F8772F58-5EFF-410E-B44F-297452D06BC6Q33947369-5F02C4E4-0F55-473E-B9BD-8172F7DBDB2CQ34026044-0E712E95-62B8-4ED4-8682-C520494BF818Q34116825-BD2F17B7-695A-47F5-9451-C5270F52375EQ34129846-7AF6FDA8-4E8B-4C66-9B79-0CA13FFBE23BQ34158534-D0E4DE0B-83D5-42BB-88A5-0C401AEB199FQ34229584-DD175702-B62F-458E-BCC5-16B5745900C9Q34244698-089353C4-EE43-4282-95B3-F2FD5B1928B0Q34292427-30CC4432-237C-4FA5-89E7-BDB0779BFC79Q34295208-3DE47790-00F4-4B07-B773-5D1C39458E24
P2860
Preclinical models: status of basic research in depression.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Preclinical models: status of basic research in depression.
@ast
Preclinical models: status of basic research in depression.
@en
Preclinical models: status of basic research in depression.
@nl
type
label
Preclinical models: status of basic research in depression.
@ast
Preclinical models: status of basic research in depression.
@en
Preclinical models: status of basic research in depression.
@nl
prefLabel
Preclinical models: status of basic research in depression.
@ast
Preclinical models: status of basic research in depression.
@en
Preclinical models: status of basic research in depression.
@nl
P2093
P1476
Preclinical models: status of basic research in depression.
@en
P2093
Elizabeth Gould
Howard K Greshenfeld
Husseini Manji
Israel Lederhendler
Lois Winsky
Maja Buncan
Michael Meaney
Ronald S Duman
Steve Zalcman
P304
P356
10.1016/S0006-3223(02)01405-1
P407
P577
2002-09-01T00:00:00Z